Replies to post #201407 on Biotech Values

[DewDiligence]

FDA approves PFE’s Eucrisa (crisaborole) for eczema:

http://www.fda.gov/NewsEvents/Newsroom/PressAnnouncements/ucm533371.htm

PFE acquired this program in the May 2016 ANAC buyout (#msg-122659881).